KUALA LUMPUR (June 8): Electronic manufacturing services provider K-One Technology Bhd said its unit has received approval from the Medical Device Authority (MDA), an agency under the Ministry of Health, to sell low dead-volume (LVD) disposable syringes with needle in Malaysia.

In a bourse filing today, the company said its wholly-owned subsidiary K-One MediTech Sdn Bhd received the approval last Friday (June 4).

“The K-One Group will sell the LDV syringes with needle as an authorised representative of Anhui Kangda Medical Products Co. Ltd based in China with the LDV syringes with needle approved under K-One MediTech Sdn Bhd by MDA.

“The MDA has approved 12 LDV syringes with needle in total, consisting of 1 ml and 3 ml LDV syringes respectively with each having six different combinations of needle gauges (ranging from 23G to 25G) and lengths (ranging from 19 mm to 38 mm) to suit various market requirements,” said K-One.

According to K-One, the approval of the LDV syringes with needle is timely as the Government is stepping up the roll out of Covid-19 vaccinations, adding that the demand for LVD syringes is expected to increase in the months ahead.

It added that the distribution and supply of the LDV syringes will not have any material impact on the issued share capital and net assets group, but is expected to contribute positively to its earnings for the financial year ending Dec 31, 2021.

K-One closed unchanged at 30 sen, with some 5.03 million shares done. This valued  the company at RM244.74 million.